Hygiene Unit - Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Bari, Italy.
Nephrology, Dialysis and Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Aldo Moro, Bari, Italy.
Hum Vaccin Immunother. 2023 Dec 15;19(3):2266932. doi: 10.1080/21645515.2023.2266932. Epub 2023 Oct 16.
Influenza and Coronavirus Disease 2019 (COVID-19) vaccination are recommended in both solid organ transplant (SOT) candidates and recipients. In Puglia, Southern Italy, an active vaccination offer program has been activated targeting these patients. This study aims at investigating vaccination coverage (VC) for both vaccines in a SOT patients' cohort, as well as at identifying the vaccination compliance determinant. This is a retrospective, population-based study. The study population consists of the SOT patients who accessed Bari's "Policlinico" General Hospital during 2017-2022. Patients were contacted and, after providing their consent, asked their immunization status regarding influenza and COVID-19 and whether they had already undergone transplant or were waiting to do so. Regression models were fitted to investigate the determinants of VCs for influenza vaccination (2021/22 and 2022/23 seasons) and for COVID-19 vaccination (three-dose base cycle, first and second booster doses). Three-hundred and ten SOT patients were identified; 85.2% (264/310) had already undergone SOT. VCs were suboptimal, especially for constant yearly influenza vaccination (17.7%) and COVID-19 vaccination's second booster (1.94%). Logistic regression highlighted that influenza VCs are higher for SOT recipients than SOT candidates, as well as for older patients, although when considering both vaccination seasons only age significantly impact the vaccination uptake. Older age was the only influential variable for COVID-19 VC. VCs for SOT patients seem to be unsatisfying. Stronger interventions are required.
流感和 2019 年冠状病毒病(COVID-19)疫苗接种均推荐用于实体器官移植(SOT)候选人和受者。在意大利南部的普利亚大区,已经为这些患者启动了一项积极的疫苗接种计划。本研究旨在调查 SOT 患者队列中这两种疫苗的接种覆盖率(VC),并确定接种的决定因素。这是一项回顾性的、基于人群的研究。研究人群包括 2017 年至 2022 年期间在巴里“Policlinico”综合医院就诊的 SOT 患者。联系患者后,在获得他们的同意后,询问他们关于流感和 COVID-19 的免疫状况,以及他们是否已经接受过移植或正在等待移植。拟合回归模型以调查流感疫苗(2021/22 和 2022/23 季节)和 COVID-19 疫苗(三剂基础周期、第一和第二加强针)接种的 VC 决定因素。确定了 310 名 SOT 患者;85.2%(264/310)已经接受了 SOT。VC 不理想,尤其是对于每年定期接种流感疫苗(17.7%)和 COVID-19 疫苗的第二加强针(1.94%)。逻辑回归突出显示,SOT 受者的流感 VC 高于 SOT 候选者,以及年龄较大的患者,尽管在考虑两个接种季节时,只有年龄显著影响疫苗接种率。年龄较大是 COVID-19 VC 的唯一有影响的变量。SOT 患者的 VC 似乎并不令人满意。需要采取更强有力的干预措施。